(Q36249219)

English

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

author name string

You-Feng Guo

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Xiao-Bing Wang

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Xiao-Ying Tian

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Yang Li

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Bin Li

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Quan Huang

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Meng Zhang

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Zhi Li

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

28 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

World Journal of Surgical Oncology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

128

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Inhibition of the met receptor tyrosine kinase signaling enhances the chemosensitivity of glioma cell lines to CDDP through activation of p38 MAPK pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Malignant astrocytic glioma: genetics, biology, and paths to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Prognostic factors for anaplastic astrocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Epidemiology and etiology of gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

AKT/PKB signaling mechanisms in cancer and chemoresistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Met, metastasis, motility and more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Met and hepatocyte growth factor/scatter factor expression in human gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Hepatocyte growth factor: a multifunctional cytokine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

1 October 2017

Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

29 June 2018

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

29 June 2018

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

29 June 2018

Proliferative potential and outcome in pediatric astrocytic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

29 June 2018

Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

27 July 2018

Epidemiology of brain tumors.

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value.

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Role of MIB1 in predicting survival in patients with glioblastomas.

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

High response rate to cisplatin/etoposide regimen in childhood low-grade glioma

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

Local chemotherapy with cisplatin-depot for glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1186%2F1477-7819-10-128

21 January 2018

In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

22 September 2018

Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

22 September 2018

Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447698

22 September 2018

Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22741575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and expression of chimeric U1/ribozyme transgenes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22741575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22741575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22741575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/22741575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1477-7819-10-128

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36249219&oldid=2198446428"